Question · asked by 1 review

Topical methyl salicylate (Theraflex-TMJ) vs placebo: Spontaneous pain in the TMJ (VAS)

Population
Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD (McNeill 1997 criteria); moderate to severe pain of minimum 3 months' duration
Intervention
Topical methyl salicylate (Theraflex-TMJ)
Comparison
placebo
Outcome
Spontaneous pain in the TMJ (VAS)

Topical methyl salicylate (Theraflex-TMJ) led to lower spontaneous TMJ pain (numerical graph rating scale) compared with placebo; GRADE not reported.

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Topical methyl salicylate (Theraflex-TMJ) vs Placebo
Spontaneous TMJ pain (numerical graph rating scale) · Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD (McNeill 1997 criteria); moderate to… · 15 days
Topical methyl salicylate (Theraflex-TMJ) led to lower spontaneous TMJ pain (numerical graph rating scale) compared with placebo; GRADE not reported.
Pharmacological interventions for pain in patients with temporomandibular disorders (2010) · Cochrane All outcomes
MD -0.90 [-1.35, -0.45]1 study · 52 participantsGRADE not reported

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Pharmacological interventions for pain in patients with temporomandibular disorders
2010 · Cochrane All outcomes
2010-08Not listedNot assessed
How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.